Xiaopeng Huang
No. 19 Xiuhua Road, Xiuying District
Haikou, 570311, China
Haikou, 570311, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
MALAT1 promotes autophagy via the mir-28-5p/IGF1R axis in nasopharyngeal carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: December 16, 2025
Neuropilin-2 Mediates Radioresistance in Nasopharyngeal Carcinoma via Wnt/β-Catenin Pathway.
Journal: Cancer management and research
Published: April 23, 2025
Efficacy and Safety of Combined PD-1 Inhibitor With Induction Chemotherapy Followed by IMRT Plus Nimotuzumab in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Analysis.
Journal: OncoTargets and therapy
Published: October 30, 2024
SIRT1 silencing ameliorates malignancy of non-small cell lung cancer via activating FOXO1.
Journal: Scientific reports
Published: May 10, 2024
ATF4 inhibits tumor development and mediates p-GCN2/ASNS upregulation in colon cancer.
Journal: Scientific reports
Published: January 30, 2024
The Prognostic Value of Serum Sialic Acid in Patients with Nasopharyngeal Carcinoma: A Propensity Score Matching Study.
Journal: Cancer management and research
Published: November 16, 2023
Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma.
Journal: Scientific reports
Published: September 21, 2023
Targeting GABARAPL1/HIF-2a axis to induce tumor cell apoptosis in nasopharyngeal carcinoma.
Journal: Iranian journal of basic medical sciences
Published: June 09, 2023
Evaluation of the Clinical Efficacy of Intensity-Modulated Radiotherapy Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Extrahepatic Oligometastasis and Prognostic Factors for Patient Survival.
Journal: International journal of general medicine
Published: January 01, 2023
Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma.
Journal: International journal of general medicine
Published: September 20, 2021
Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma.
Journal: Drug design, development and therapy
Published: December 29, 2019
An open-label, single-arm phase II clinical study of induction chemotherapy and sequential Nimotuzumab combined with concurrent chemoradiotherapy in N3M0 stage nasopharyngeal carcinoma.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: January 06, 2019
Last Updated: 09/26/2026